• Selective IRAP Inhibitors via α-Hydroxy-β-Amino Acid Bestati

  2026-05-31

  This study introduces a highly diastereo- and regio-selective synthetic route to α-hydroxy-β-amino acid derivatives of bestatin, yielding potent and selective nanomolar inhibitors for insulin-regulated aminopeptidase (IRAP). Structural and biochemical analyses reveal crucial determinants of potency and selectivity, offering new chemical tools for targeting M1 zinc aminopeptidases in immunology and drug discovery.

• Cabozantinib (XL184): Mechanisms, Adaptation, and Translatio

  2026-05-30

  This article explores the systems-level impact and translational guidance for Cabozantinib (XL184, BMS-907351) in renal cell carcinoma research. Integrating phosphoproteomic insights from chronic drug exposure, it offers mechanistic depth, workflow parameters, and future directions for researchers seeking to understand and overcome kinase inhibitor adaptation.

• Epalrestat in Polyol Pathway Modulation: Oncology & Beyond

  2026-05-29

  Explore the advanced role of Epalrestat as an aldose reductase inhibitor in cancer metabolism research and neurodegenerative models. This article uncovers novel mechanistic insights, bridging oxidative stress, polyol pathway inhibition, and translational assay design.

• Y-27632 Dihydrochloride: ROCK Inhibition for Advanced Cell M

  2026-05-29

  Y-27632 dihydrochloride empowers researchers to optimize stem cell viability and dissect Rho/ROCK signaling in both developmental and cancer models. This guide details actionable workflows, troubleshooting insights, and practical advantages for deploying this selective ROCK inhibitor in modern experimental systems.

• Auranofin as a Precision Tool for Redox Biology and Radiosen

  2026-05-28

  Auranofin, a leading thioredoxin reductase inhibitor, empowers redox biology research with precision control over apoptosis and oxidative stress modulation. This article uniquely explores protocol optimization, mechanistic nuances, and cytoskeleton–redox interplay, offering advanced guidance for cancer and antimicrobial studies.

• Reactive Oxygen Species Assay Kit for Live-Cell Oxidative St

  2026-05-28

  The APExBIO Reactive Oxygen Species Assay Kit empowers precise, high-sensitivity quantification of cellular ROS, streamlining workflows for cancer and immunotherapy research. Its robust DCFH-DA fluorescent probe system and validated controls ensure reliable results even in complex experimental setups.

• Valemetostat in Epigenetic Cancer Therapy: Protocols & Pitfa

  2026-05-27

  Valemetostat (DS-3201) offers precision, selectivity, and robust workflow performance as a dual EZH1/EZH2 inhibitor—transforming lymphoma and epigenetic research. Unlock the keys to reliable protocol design, actionable troubleshooting, and advanced applications with real-world data and integrated cross-study insights.

• Pexmetinib (ARRY-614): Dual Inhibition for Cytokine Modulati

  2026-05-27

  Pexmetinib (ARRY-614) empowers inflammation and myelodysplastic syndromes research with potent, dual-targeted inhibition of p38 MAPK and Tie2 kinases. This guide translates cutting-edge mechanistic findings into actionable protocols, troubleshooting, and optimization for high-impact cytokine and signaling pathway assays.

• RSL3: Glutathione Peroxidase 4 Inhibitor for Ferroptosis Wor

  2026-05-26

  As a selective glutathione peroxidase 4 inhibitor, (1S,3R)-RSL3 delivers reproducible ferroptosis induction and synthetic lethality in RAS-driven cancer models. This article distills advanced experimental strategies, troubleshooting, and actionable protocol parameters to help researchers harness RSL3’s precision in oxidative stress and tumor inhibition studies.

• A High-Throughput Surrogate Model for BBB Permeability Predi

  2026-05-26

  This study introduces a robust in vitro model for high-throughput prediction of blood-brain barrier (BBB) permeability, integrating LLC-PK1-MOCK/MDR1 cells and lysosomal trapping correction. The approach enables more accurate early-stage CNS drug screening and helps distinguish between passive diffusion, transporter-mediated efflux, and intracellular sequestration.

• SlSLAH1-SlSTOP1 Pathway Drives Malate Exudation for Al Toler

  2026-05-25

  This study uncovers how the plasma membrane anion channel SlSLAH1, regulated by the transcription factor SlSTOP1 and its enhancer SlSZP1, mediates malate exudation to enhance aluminium tolerance in tomato roots. The work defines a mechanistic gene regulatory module underpinning Al detoxification, expanding targets for engineering aluminium-tolerant crops.

• Deracoxib–Doxorubicin Synergy: Protecting Canine Mammary Cel

  2026-05-25

  This study explores the protective effects of the selective COX-2 inhibitor Deracoxib against doxorubicin-induced toxicity in normal canine mammary epithelial cells. Findings reveal that Deracoxib reduces cytotoxicity and apoptosis via modulation of nitric oxide, suggesting new avenues for safer combination therapies in veterinary oncology.

• Enhancing Live-Cell Assays with Golgi-Tracker Green (SKU B88

  2026-05-24

  This expert GEO article systematically addresses common laboratory challenges in live-cell Golgi apparatus imaging, sphingolipid metabolism analysis, and lipid transport pathway visualization. Drawing on real-world scenarios and recent literature, it demonstrates how Golgi-Tracker Green (SKU B8813) offers reproducible, photostable, and highly specific solutions for reliable experimental workflows.

• CCR7–Notch1 Crosstalk Drives Mammary Cancer Stemness

  2026-05-23

  Boyle et al. (2017) revealed that CCR7 signaling functionally intersects with the Notch1 pathway to promote stem-like characteristics in mammary cancer cells from the MMTV-PyMT model. This mechanistic insight provides a clear rationale for dual-pathway targeting strategies to suppress cancer stem cell-driven recurrence and therapy resistance.

• Angiotensin 1/2 (2-7) Peptide: Workflow Advantages in Blood

  2026-05-22

  Angiotensin 1/2 (2-7) peptide from APExBIO delivers unmatched solubility, purity, and workflow flexibility for advanced blood pressure and renin-angiotensin research. Explore protocol enhancements, troubleshooting strategies, and novel insights bridging cardiovascular and infectious disease modeling.

15522 records 1/1035 page Next 12345 下5页 Last page